LON:EMIS EMIS Group (EMIS) Share Price, News & Analysis GBX 1,920 0.00 (0.00%) (As of 10/27/2023) Add Compare Share Share Today's Range 1,920▼ 1,92050-Day Range 1,920▼ 1,92052-Week Range 1,250▼ 1,944Volume433,828 shsAverage Volume675,394 shsMarket Capitalization£1.23 billionP/E Ratio4,085.11Dividend Yield2.19%Price TargetN/A Stock AnalysisStock AnalysisDividendHeadlinesInsider TradesStock AnalysisDividendHeadlinesInsider Trades Get EMIS Group alerts: Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About EMIS Group Stock (LON:EMIS)EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.Read More EMIS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMIS Stock News HeadlinesSeptember 2, 2024 | msn.comHDFC Bank executive on Apple partnership: ‘Temporary break, reviewing cost-to-income’, says reportAugust 25, 2024 | msn.comPassenger vehicle sales stagnate in FY25 amid waning demand, high inventorySeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 22, 2024 | msn.comRise in demand of under ₹30 lakh homesAugust 18, 2024 | msn.comRBI Retains Repo Rate And LTCG Tax Amendment, Real Estate Industry Stalwarts ReactAugust 14, 2024 | msn.comHomebuyers' forum demands investigation into RERA-K decisions in KarnatakaAugust 11, 2024 | msn.comInsurance providers step up to address India’s disability costsAugust 11, 2024 | msn.comBad News for Bank Customers: This Bank Increases Loan EMIs; Here’s WhySeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 9, 2024 | msn.comWill the wait of home loan borrowers for reduction in EMIs be a reality in October this year? Here’s how to make the best of falling ratesAugust 8, 2024 | msn.comStability in mortgage rate to help maintain strong housing demand: Realtors on RBI policyAugust 8, 2024 | msn.comRBI Policy review: No impact on home loan EMIs as repo rate kept unchanged, sets positive tone for the realty sectorAugust 3, 2024 | msn.comHow CrowdStrike glitch lifted the lid on ‘outdated’ NHS IT systemJuly 24, 2024 | msn.comKent and Medway GPs face backlog after 34,000 appointments disrupted due to IT outageJuly 23, 2024 | msn.comPharmacy prescriptions delayed after IT outageJuly 22, 2024 | msn.comIT working but delays possible after outage, says NHSJuly 22, 2024 | msn.comMicrosoft IT outage live: CrowdStrike says ‘significant number’ of impacted devices back onlineJuly 20, 2024 | uk.news.yahoo.comIT outage 'causing disruption in majority of GP practices' in EnglandSee More Headlines Receive EMIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2018Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:EMIS CUSIPN/A CIKN/A Webwww.emisgroupplc.com Phone+44-113-3803000FaxN/AEmployees1,560Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.47 Trailing P/E Ratio4,085.11 Forward P/E Ratio27.25 P/E Growth1.37Net Income£30.48 million Net Margins17.23% Pretax MarginN/A Return on Equity23.17% Return on Assets7.99% Debt Debt-to-Equity Ratio2.96 Current Ratio1.07 Quick Ratio1.83 Sales & Book Value Annual Sales£176.86 million Price / Sales6.97 Cash FlowGBX 87.67 per share Price / Cash Flow21.90 Book ValueGBX 210 per share Price / Book9.14Miscellaneous Outstanding Shares64,160,000Free FloatN/AMarket Cap£1.23 billion OptionableNot Optionable Beta-0.13 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Andrew John Thorburn (Age 61)CEO & Executive Director Comp: $1.01MMr. Peter J. Southby (Age 50)CFO & Executive Director Comp: $672kMr. Richard JarvisChief Technology OfficerDr. Shaun O'Hanlon (Age 58)Chief Medical Officer Ms. Suzy FosterChief Executive Officer of EMIS Health & EMIS EnterprisePankaj MistryChief Information Security OfficerChristine BensonCompany SecretaryMore ExecutivesKey CompetitorsCranewareLON:CRWInstemLON:INSKoothLON:KOOCambridge CognitionLON:COGRenalytixLON:RENXView All CompetitorsInsidersPeter SouthbyBought 7 shares on 9/15/2023Total: £13,440.00 ($1,920.00/share)View All Insider Transactions EMIS Stock Analysis - Frequently Asked Questions How have EMIS shares performed this year? EMIS Group's stock was trading at GBX 1,920 at the beginning of 2024. Since then, EMIS stock has increased by 0.0% and is now trading at GBX 1,920. View the best growth stocks for 2024 here. How were EMIS Group's earnings last quarter? EMIS Group plc (LON:EMIS) announced its quarterly earnings results on Wednesday, March, 14th. The company reported $47.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $46.30 by $0.90. The business had revenue of $160.35 million for the quarter. EMIS Group had a net margin of 17.23% and a trailing twelve-month return on equity of 23.17%. How do I buy shares of EMIS Group? Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of EMIS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that EMIS Group investors own include RM (RM), Shire (SHP), The Character Group (CCT), Babcock International Group (BAB), Croda International (CRDA), James Halstead (JHD) and Micro Focus International (MCRO). This page (LON:EMIS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMIS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EMIS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.